,X,Filing Date,Trade Date,Ticker,Insider Name,Title,Trade Type  ,Price,Qty,Owned,ΔOwn,Value,1d,1w,1m,6m
0,,,,,,,,,,,,,,,,
1,DM,2021-07-28 16:21:17,2021-07-26,DGX,Rusckowski Stephen H,"COB, CEO, Pres",S - Sale+OE,$140.01,"-38,601","284,427",-12%,"-$5,404,544",,,,
2,D,2021-07-28 16:18:33,2021-07-27,DGX,Wilensky Gail R,Dir,S - Sale+OE,$139.30,"-12,222","31,220",-28%,"-$1,702,470",,,,
3,,2021-05-11 16:27:00,2021-05-07,DGX,Doherty Catherine T.,"SVP, Group Exec. Clin. Fran.",S - Sale,$139.96,"-8,536","72,835",-10%,"-$1,194,724",,,,
4,D,2021-05-07 16:32:48,2021-05-05,DGX,Prevoznik Michael E,"SVP, GC",S - Sale+OE,$137.00,"-44,939","45,385",-50%,"-$6,156,643",,,,
5,,2021-03-11 16:31:38,2021-03-10,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$120.47,"-5,574","45,363",-11%,"-$671,500",,,,
6,,2021-03-01 16:29:59,2021-02-25,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$115.49,-801,"45,372",-2%,"-$92,507",,,,
7,,2021-02-25 16:39:48,2021-02-24,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$116.95,"-1,188","46,172",-3%,"-$138,937",,,,
8,D,2020-12-28 16:27:20,2020-12-24,DGX,Guinan Mark,"EVP, CFO",S - Sale+OE,$120.37,"-81,756","73,579",-53%,"-$9,840,673",,,,
9,D,2020-11-27 16:38:37,2020-11-24,DGX,Wilensky Gail R,Dir,S - Sale+OE,$126.02,"-6,111","29,857",-17%,"-$770,120",,,,
10,,2020-11-24 16:31:08,2020-11-23,DGX,Stanzione Daniel,Dir,S - Sale,$126.30,"-11,223","28,349",-28%,"-$1,417,459",,,,
11,D,2020-10-23 16:42:24,2020-10-21,DGX,Deppe Michael J,"VP, Corp. Controller, CAO",S - Sale+OE,$125.00,"-10,450","25,728",-29%,"-$1,306,250",,,,
12,D,2020-10-19 16:17:18,2020-10-16,DGX,Rusckowski Stephen H,"COB, CEO, Pres",S - Sale+OE,$120.00,"-291,997","237,747",-55%,"-$35,039,640",,,,
13,D,2020-10-15 16:45:48,2020-10-14,DGX,Prevoznik Michael E,"SVP, GC",S - Sale+OE,$119.00,"-35,591","45,261",-44%,"-$4,235,329",,,,
14,D,2020-09-04 16:18:23,2020-09-02,DGX,Doherty Catherine T.,"SVP, Group Exec. Clin. Fran.",S - Sale+OE,$110.60,"-58,392","72,467",-45%,"-$6,458,343",,,,
15,D,2020-06-10 16:33:00,2020-06-08,DGX,Guinan Mark,"EVP, CFO",S - Sale+OE,$117.23,"-72,596","73,579",-50%,"-$8,510,585",,,,
16,D,2020-06-10 16:31:51,2020-06-08,DGX,Ring Timothy M,Dir,S - Sale+OE,$116.60,"-11,730","20,505",-36%,"-$1,367,718",,,,
17,D,2020-04-28 16:45:00,2020-04-27,DGX,Rusckowski Stephen H,"COB, CEO, Pres",S - Sale+OE,$112.01,"-11,717","237,747",-5%,"-$1,312,433",,,,
18,,2020-04-28 16:37:30,2020-04-27,DGX,Eglinton Manner Carrie,"SVP, Advanced Diagnostics",S - Sale,$111.02,"-5,000","22,390",-18%,"-$555,075",,,,
19,,2020-03-17 16:37:15,2020-03-16,DGX,Davis J. E.,"EVP, General Diagnostics",S - Sale,$87.75,"-3,513","38,086",-8%,"-$308,251",,,,
20,,2020-03-12 17:00:33,2020-03-11,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$104.25,"-2,175","45,196",-5%,"-$226,744",,,,
21,,2020-03-12 16:57:23,2020-03-11,DGX,Doherty Catherine T.,"SVP, Group Exec. Clin. Fran.",S - Sale,$104.25,"-2,501","72,414",-3%,"-$260,729",,,,
22,D,2020-03-12 16:55:43,2020-03-10,DGX,Rusckowski Stephen H,"COB, CEO, Pres",S - Sale+OE,$112.19,-100,"237,747",0%,"-$11,219",,,,
23,D,2020-03-10 16:38:33,2020-03-06,DGX,Rusckowski Stephen H,"COB, CEO, Pres",S - Sale+OE,$112.67,"-230,178","226,560",-50%,"-$25,934,978",,,,
24,M,2020-02-28 17:53:01,2020-02-26,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$109.68,"-1,011","45,192",-2%,"-$110,884",,,,
25,M,2020-02-28 17:51:53,2020-02-26,DGX,Doherty Catherine T.,"SVP, Group Exec. Clin. Fran.",S - Sale,$109.68,"-1,157","72,415",-2%,"-$126,898",,,,
26,M,2020-02-28 17:50:43,2020-02-26,DGX,Davis J. E.,"EVP, General Diagnostics",S - Sale,$109.68,"-1,610","38,105",-4%,"-$176,578",,,,
27,,2020-02-26 16:34:07,2020-02-25,DGX,Davis J. E.,"EVP, General Diagnostics",S - Sale,$112.73,-598,"40,902",-1%,"-$67,413",,,,
28,,2020-02-26 16:31:13,2020-02-25,DGX,Doherty Catherine T.,"SVP, Group Exec. Clin. Fran.",S - Sale,$112.73,-405,"74,345",-1%,"-$45,656",,,,
29,D,2020-01-03 16:39:20,2020-01-02,DGX,Davis J. E.,"EVP, General Diagnostics",S - Sale+OE,$105.58,"-143,537","36,543",-80%,"-$15,153,864",,,,
30,D,2019-12-04 16:32:21,2019-11-27,DGX,Prevoznik Michael E,"SVP, GC",S - Sale+OE,$107.43,"-44,556","44,541",-50%,"-$4,786,564",,,,
31,D,2019-11-27 16:43:29,2019-11-26,DGX,Wilensky Gail R,Dir,S - Sale+OE,$107.17,"-8,000","28,326",-22%,"-$857,352",,,,
32,D,2019-09-19 16:29:10,2019-09-17,DGX,Deppe Michael J,"VP, Corp. Controller, CAO",S - Sale+OE,$106.00,"-5,000","24,353",-17%,"-$530,000",,,,
33,D,2019-06-17 16:36:32,2019-06-13,DGX,Rusckowski Stephen H,"COB, Pres, CEO",S - Sale+OE,$100.00,"-244,565","213,049",-53%,"-$24,456,500",,,,
34,D,2019-06-17 16:35:13,2019-06-13,DGX,Guinan Mark,"EVP, CFO",S - Sale+OE,$100.00,"-73,005","66,017",-53%,"-$7,300,500",,,,
35,D,2019-04-26 16:29:33,2019-04-24,DGX,Davis J. E.,"EVP, General Diagnostics",S - Sale+OE,$95.00,"-47,574","36,534",-57%,"-$4,519,530",,,,
36,,2019-04-10 16:30:35,2019-04-08,DGX,Davis J. E.,"EVP, General Diagnostics",S - Sale,$90.29,"-8,000","36,534",-18%,"-$722,332",,,,
37,D,2019-04-08 16:24:57,2019-04-04,DGX,Doherty Catherine T.,"SVP, Group Exec. Clin. Fran.",S - Sale+OE,$90.59,"-66,382","71,450",-48%,"-$6,013,739",,,,
38,,2019-03-05 16:32:54,2019-03-04,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$86.81,"-3,373","44,467",-7%,"-$292,810",,,,
39,,2019-03-05 16:26:44,2019-03-04,DGX,Cunningham Everett,"SVP, Commercial",S - Sale,$86.81,"-3,892","39,032",-9%,"-$337,865",,,,
40,M,2019-02-28 17:24:59,2019-02-26,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$86.65,"-1,412","44,462",-3%,"-$122,352",,,,
41,M,2019-02-28 17:11:58,2019-02-26,DGX,Cunningham Everett,"SVP, Commercial",S - Sale,$86.64,"-1,496","38,921",-4%,"-$129,613",,,,
42,,2019-02-27 18:34:05,2019-02-25,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$88.23,-336,"46,780",-1%,"-$29,645",,,,
43,,2019-02-27 18:19:48,2019-02-25,DGX,Cunningham Everett,"SVP, Commercial",S - Sale,$88.23,-326,"41,529",-1%,"-$28,763",,,,
44,D,2019-02-25 20:08:43,2019-02-22,DGX,Wilensky Gail R,Dir,S - Sale+OE,$87.78,"-8,000","26,604",-23%,"-$702,216",,,,
45,D,2018-07-12 16:53:50,2018-07-10,DGX,Prevoznik Michael E,"SVP, GC",S - Sale+OE,$113.07,"-30,780","44,706",-41%,"-$3,480,141",,,,
46,D,2018-07-12 16:52:22,2018-07-10,DGX,Cunningham Everett,"SVP, Commercial",S - Sale+OE,$112.00,"-40,328","38,877",-51%,"-$4,516,736",,,,
47,D,2018-07-05 16:38:07,2018-07-02,DGX,Cunningham Everett,"SVP, Commercial",S - Sale+OE,$109.67,"-68,069","38,877",-64%,"-$7,465,043",,,,
48,,2018-05-30 16:38:20,2018-05-29,DGX,Leiden Jeffrey M,Dir,S - Sale,$105.61,"-1,644","6,000",-22%,"-$173,623",,,,
49,D,2018-05-29 16:39:51,2018-05-25,DGX,Rusckowski Stephen H,"COB, Pres, CEO",S - Sale+OE,$107.00,"-168,490","191,069",-47%,"-$18,028,430",,,,
50,D,2018-05-29 16:37:26,2018-05-25,DGX,Guinan Mark,"EVP, CFO",S - Sale+OE,$105.71,"-61,533","58,200",-51%,"-$6,504,682",,,,
51,D,2018-03-12 16:33:53,2018-03-08,DGX,Cohen Jon R,"SVP, Group Exec. Diag. Sol.",S - Sale+OE,$104.20,"-83,669","31,757",-72%,"-$8,717,937",,,,
52,,2018-03-06 19:41:42,2018-03-05,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$101.00,"-4,128","44,666",-8%,"-$416,928",,,,
53,,2018-03-06 19:39:53,2018-03-05,DGX,Davis J. E.,"EVP, General Diagnostics",S - Sale,$101.00,"-5,122","37,067",-12%,"-$517,322",,,,
54,,2018-03-06 19:36:34,2018-03-05,DGX,Doherty Catherine T.,"SVP, Group Exec. Clin. Fran.",S - Sale,$101.00,"-5,556","71,777",-7%,"-$561,156",,,,
55,M,2018-03-01 17:08:38,2018-02-27,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$104.41,"-1,423","44,660",-3%,"-$148,576",,,,
56,M,2018-03-01 16:58:46,2018-02-27,DGX,Doherty Catherine T.,"SVP, Group Exec. Clin. Fran.",S - Sale,$104.38,"-1,820","71,777",-2%,"-$189,971",,,,
57,M,2018-03-01 16:56:28,2018-02-27,DGX,Davis J. E.,"EVP, General Diagnostics",S - Sale,$104.42,"-1,798","37,023",-5%,"-$187,749",,,,
58,,2018-02-27 16:40:22,2018-02-26,DGX,Klug Robert A,"VP, Corporate Controller",S - Sale,$103.66,"-1,157","3,903",-23%,"-$119,932",,,,
59,,2018-02-27 16:38:11,2018-02-26,DGX,Doherty Catherine T.,"SVP, Group Exec. Clin. Fran.",S - Sale,$102.74,-397,"74,153",-1%,"-$40,788",,,,
60,,2018-02-27 16:37:02,2018-02-26,DGX,Davis J. E.,"EVP, General Diagnostics",S - Sale,$102.74,-494,"39,677",-1%,"-$50,754",,,,
61,D,2018-01-31 16:33:27,2018-01-29,DGX,Rusckowski Stephen H,"COB, Pres, CEO",S - Sale+OE,$107.00,"-106,840","166,116",-39%,"-$11,431,880",,,,
62,D,2018-01-26 16:43:07,2018-01-24,DGX,Doherty Catherine T.,"SVP, Group Exec. Clin. Fran.",S - Sale+OE,$104.00,"-21,294","73,249",-23%,"-$2,214,576",,,,
63,D,2018-01-04 16:34:34,2018-01-02,DGX,Davis J. E.,"EVP, General Diagnostics",S - Sale+OE,$98.68,"-63,880","38,053",-63%,"-$6,303,359",,,,
64,D,2017-09-13 18:20:10,2017-09-11,DGX,Stanzione Daniel,Dir,S - Sale+OE,$108.07,"-40,900","34,675",-54%,"-$4,419,940",,,,
65,DM,2017-09-13 18:18:29,2017-09-11,DGX,Rusckowski Stephen H,"COB, Pres, CEO",S - Sale+OE,$108.16,"-59,235","166,116",-26%,"-$6,406,845",,,,
66,D,2017-09-07 16:43:31,2017-09-05,DGX,Stanzione Daniel,Dir,S - Sale+OE,$108.01,"-3,803","34,675",-10%,"-$410,762",,,,
67,D,2017-09-07 16:40:46,2017-09-05,DGX,Rusckowski Stephen H,"COB, Pres, CEO",S - Sale+OE,$108.03,"-2,525","166,116",-1%,"-$272,768",,,,
68,,2017-08-08 16:27:05,2017-08-04,DGX,Leiden Jeffrey M,Dir,S - Sale,$106.66,-296,"6,000",-5%,"-$31,571",,,,
69,,2017-07-31 16:42:04,2017-07-27,DGX,Leiden Jeffrey M,Dir,S - Sale,$108.73,"-1,304","6,296",-17%,"-$141,783",,,,
70,D,2017-06-21 16:28:04,2017-06-19,DGX,Cohen Jon R,"SVP, Group Exec. Diag. Sol.",S - Sale+OE,$107.55,"-106,900","73,183",-59%,"-$11,497,134",,,,
71,D,2017-06-21 16:27:22,2017-06-19,DGX,Doherty Catherine T.,"SVP, Group Exec. Clin. Fran.",S - Sale+OE,$107.55,"-59,762","73,195",-45%,"-$6,427,118",,,,
72,D,2017-04-26 16:34:43,2017-04-24,DGX,Britell Jenne K,Dir,S - Sale+OE,$104.03,"-6,111","19,903",-23%,"-$635,727",0,+1,,
73,D,2017-04-24 16:18:33,2017-04-20,DGX,Prevoznik Michael E,"SVP, GC",S - Sale+OE,$100.00,"-29,513","45,119",-40%,"-$2,951,300",+2,+1,,
74,D,2017-03-20 16:37:01,2017-03-16,DGX,Prevoznik Michael E,"SVP, GC",S - Sale+OE,$100.00,"-13,987","45,130",-24%,"-$1,398,700",-1,0,-2,
75,,2017-03-06 16:40:44,2017-03-03,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$98.29,"-4,478","45,130",-9%,"-$440,143",0,0,0,
76,M,2017-03-06 16:39:20,2017-03-02,DGX,Doherty Catherine T.,"SVP, Group Exec. Clin. Fran.",S - Sale,$98.28,"-7,162","77,922",-8%,"-$703,908",0,0,0,
77,,2017-03-03 17:15:45,2017-03-01,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$97.77,-470,"49,608",-1%,"-$45,952",0,0,0,
78,,2017-02-24 16:32:23,2017-02-22,DGX,Ziegler John B,Dir,S - Sale,$95.51,"-2,000","16,557",-11%,"-$191,016",0,+1,+1,
79,,2017-02-17 16:35:59,2017-02-15,DGX,Doherty Catherine T.,"SVP, Clin. Franchise Solutions",S - Sale,$94.65,"-1,615","77,147",-2%,"-$152,858",0,+2,+4,
80,,2017-02-15 16:43:45,2017-02-13,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$93.76,"-1,200","44,301",-3%,"-$112,512",0,0,+4,
81,D,2017-02-06 16:36:55,2017-02-02,DGX,Prevoznik Michael E,"SVP, GC",S - Sale+OE,$92.39,"-45,000","46,795",-49%,"-$4,157,595",0,+1,+6,
82,D,2017-02-01 20:23:55,2017-01-30,DGX,Doherty Catherine T.,"SVP, Clin. Franchise Solutions",S - Sale+OE,$90.58,"-80,000","77,029",-51%,"-$7,246,362",0,0,+6,
83,D,2016-11-17 17:25:28,2016-11-15,DGX,Pfeiffer Gary M,Dir,S - Sale+OE,$85.09,"-42,643","13,698",-76%,"-$3,628,425",0,+2,+8,
84,D,2016-08-22 16:53:30,2016-08-19,DGX,Britell Jenne K,Dir,S - Sale+OE,$84.76,"-4,000","19,885",-17%,"-$339,052",-1,-2,-2,+14
85,D,2016-08-11 16:32:05,2016-08-10,DGX,Britell Jenne K,Dir,S - Sale+OE,$85.20,"-4,000","19,885",-17%,"-$340,808",0,-2,-6,+10
86,D,2016-08-04 16:46:18,2016-08-03,DGX,Leiden Jeffrey M,Dir,S - Sale+OE,$85.62,"-6,345","6,027",-51%,"-$543,262",0,-1,-4,+9
87,,2016-07-27 16:32:51,2016-07-25,DGX,Ziegler John B,Dir,S - Sale,$84.36,"-1,000","18,557",-5%,"-$84,359",+1,+1,-1,+10
88,D,2016-06-01 16:39:08,2016-05-27,DGX,Doherty Catherine T.,"SVP, Clin. Franchise Solutions",S - Sale+OE,$77.27,"-47,334","80,449",-37%,"-$3,657,309",+1,+1,+4,+15
89,D,2016-05-16 16:25:25,2016-05-12,DGX,Britell Jenne K,Dir,S - Sale+OE,$75.68,"-8,000","17,680",-31%,"-$605,456",-1,0,+1,+7
90,D,2016-05-11 16:21:09,2016-05-09,DGX,Cunningham Everett,"SVP, Commercial",S - Sale+OE,$76.26,"-56,312","32,326",-64%,"-$4,294,396",-1,0,+3,+9
91,D,2016-05-09 16:19:17,2016-05-06,DGX,Cunningham Everett,"SVP, Commercial",S - Sale+OE,$76.00,"-50,447","32,326",-61%,"-$3,833,972",0,-1,+2,+7
92,D,2016-04-27 16:19:31,2016-04-25,DGX,Doherty Catherine T.,"SVP, Clin. Franchise Solutions",S - Sale+OE,$74.45,"-29,550","80,890",-27%,"-$2,199,916",-1,-1,+2,+12
93,,2016-03-03 16:21:42,2016-03-01,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$68.22,"-3,815","46,680",-8%,"-$260,265",-1,-2,+4,+22
94,,2015-08-13 16:49:10,2015-08-12,DGX,Baldwin John C Md,Dir,S - Sale,$72.00,"-2,266","12,949",-15%,"-$163,152",+1,+2,-9,-14
95,,2015-08-10 16:21:20,2015-08-06,DGX,Ziegler John B,Dir,S - Sale,$74.35,"-2,200","16,965",-11%,"-$163,570",-1,-1,-10,-17
96,,2015-03-03 18:29:23,2015-03-03,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$71.16,"-3,261","46,681",-7%,"-$232,043",+1,0,+8,-2
97,,2015-02-18 18:39:07,2015-02-17,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$71.41,-488,"47,580",-1%,"-$34,848",0,-1,+7,+4
98,,2015-02-18 18:38:29,2015-02-17,DGX,Guinan Mark,"SVP, CFO",S - Sale,$71.74,-280,"40,236",-1%,"-$20,087",0,-1,+7,+4
99,D,2015-02-12 16:40:19,2015-02-11,DGX,Stanzione Daniel,Dir,S - Sale+OE,$70.97,"-8,000","26,337",-23%,"-$567,755",0,0,+2,+2
100,D,2015-02-05 16:50:23,2015-02-04,DGX,Pfeiffer Gary M,Dir,S - Sale+OE,$72.43,"-8,000","16,851",-32%,"-$579,466",-2,0,0,+6
101,D,2015-02-05 16:44:48,2015-02-04,DGX,Wilensky Gail R,Dir,S - Sale+OE,$72.34,"-8,000","18,851",-30%,"-$578,687",-2,0,0,+6
102,D,2015-02-04 18:37:15,2015-02-03,DGX,Ziegler John B,Dir,S - Sale+OE,$71.88,"-8,000","16,825",-32%,"-$575,040",0,-2,+1,+5
103,,2015-02-04 18:34:41,2015-02-02,DGX,Bongiorno Thomas F,"VP, Corporate Controller",S - Sale,$71.50,"-3,000","15,641",-16%,"-$214,500",0,-2,+1,+5
104,D,2014-11-20 17:19:13,2014-11-18,DGX,Bongiorno Thomas F,"VP, Corporate Controller",S - Sale+OE,$64.00,"-10,000","18,527",-35%,"-$640,000",+1,+1,+4,+27
105,DM,2014-11-18 16:29:24,2014-11-14,DGX,Cohen Jon R,"SVP, Chief Medical Officer",S - Sale+OE,$63.13,"-160,029","59,711",-73%,"-$10,102,834",-1,+1,0,+18
106,D,2014-11-12 16:29:03,2014-11-10,DGX,Pfeiffer Gary M,Dir,S - Sale+OE,$61.69,"-10,000","16,851",-37%,"-$616,900",+1,+2,+3,+15
107,D,2014-11-05 16:22:27,2014-11-03,DGX,Doherty Catherine T.,"SVP, Physician Services Bus.",S - Sale+OE,$62.19,"-23,667","79,783",-23%,"-$1,471,910",+4,+4,+7,+18
108,D,2014-08-11 17:07:12,2014-08-08,DGX,Doherty Catherine T.,"SVP, Clinical Franchises",S - Sale+OE,$60.12,"-25,000","79,753",-24%,"-$1,502,900",-1,-1,+5,+14
109,D,2014-08-05 16:32:21,2014-08-04,DGX,Prevoznik Michael E,"SVP, GC",S - Sale+OE,$61.01,"-14,377","47,900",-23%,"-$877,182",0,+1,+5,+21
110,D,2014-07-31 16:33:14,2014-07-30,DGX,Prevoznik Michael E,"SVP, GC",S - Sale+OE,$62.51,"-16,384","47,893",-25%,"-$1,024,103",0,-1,+1,+17
111,D,2014-07-31 16:29:29,2014-07-30,DGX,Britell Jenne K,Dir,S - Sale+OE,$62.37,"-8,000","15,151",-35%,"-$498,960",0,-1,+1,+17
112,D,2014-07-29 16:44:18,2014-07-29,DGX,Baldwin John C Md,Dir,S - Sale+OE,$62.31,"-8,000","12,875",-38%,"-$498,480",0,-1,+1,+16
113,D,2014-07-29 16:39:47,2014-07-28,DGX,Bongiorno Thomas F,"VP, Corporate Controller",S - Sale+OE,$61.72,"-4,000","18,321",-18%,"-$246,869",0,-1,+1,+16
114,DM,2014-07-28 16:35:34,2014-07-24,DGX,Ziegler John B,Dir,S - Sale+OE,$61.90,"-8,000","16,825",-32%,"-$495,200",0,-2,+1,+16
115,D,2014-05-22 17:57:33,2014-05-22,DGX,Ziegler John B,Dir,S - Sale+OE,$57.65,"-2,973","16,825",-15%,"-$171,402",0,+4,+3,+13
116,D,2014-05-09 16:33:59,2014-05-07,DGX,Pfeiffer Gary M,Dir,S - Sale+OE,$55.95,"-10,000","13,927",-42%,"-$559,511",0,+1,+8,+7
117,,2014-05-07 16:22:34,2014-05-05,DGX,Guinan Mark,"SVP, CFO",P - Purchase,$55.51,"+4,000","44,222",+10%,"+$222,023",+2,+2,+10,+12
118,D,2014-05-02 16:41:33,2014-04-30,DGX,Stanzione Daniel,Dir,S - Sale+OE,$55.75,"-30,000","22,151",-58%,"-$1,672,374",0,+3,+8,+15
119,,2014-03-05 17:04:42,2014-03-04,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$53.00,-778,"47,738",-2%,"-$41,233",+1,+4,+17,+22
120,D,2014-02-28 16:35:27,2014-02-27,DGX,Britell Jenne K,Dir,S - Sale+OE,$52.74,"-10,000","12,227",-45%,"-$527,393",-1,-1,+9,+19
121,,2014-02-27 17:17:17,2014-02-27,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$52.99,-827,"48,970",-2%,"-$43,826",0,-1,+10,+20
122,,2014-02-20 16:22:22,2014-02-19,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$52.26,"-2,860","50,288",-5%,"-$149,472",0,0,+5,+19
123,D,2014-02-19 16:25:37,2014-02-18,DGX,Wilensky Gail R,Dir,S - Sale+OE,$52.93,"-30,000","15,927",-65%,"-$1,588,041",0,+1,+6,+18
124,D,2014-02-14 16:20:34,2014-02-12,DGX,Buehler William F,Dir,S - Sale+OE,$52.15,"-30,000","26,225",-53%,"-$1,564,449",+1,+1,+3,+19
125,,2014-02-07 16:58:38,2014-02-06,DGX,Main Timothy L,Dir,P - Purchase,$50.71,"+5,000","5,658",+760%,"+$253,526",+2,+3,+4,+19
126,D,2013-11-13 16:33:54,2013-11-11,DGX,Prevoznik Michael E,"SVP, GC",S - Sale+OE,$64.02,"-24,239","49,798",-33%,"-$1,551,686",0,-2,-14,-7
127,DM,2013-11-05 16:35:40,2013-11-04,DGX,Bongiorno Thomas F,"VP, Corporate Controller",S - Sale+OE,$62.49,"-16,667","17,278",-49%,"-$1,041,508",+1,+2,-3,-10
128,,2013-11-05 16:33:59,2013-11-05,DGX,Baldwin John C Md,Dir,S - Sale,$63.00,-658,"9,951",-6%,"-$41,454",+1,+2,-3,-10
129,D,2013-11-04 16:39:03,2013-10-31,DGX,Baldwin John C Md,Dir,S - Sale+OE,$59.70,"-8,000","10,609",-43%,"-$477,600",+1,+2,-1,-10
130,D,2013-10-30 16:27:47,2013-10-29,DGX,Bongiorno Thomas F,"VP, Corporate Controller",S - Sale+OE,$59.00,"-6,000","17,249",-26%,"-$354,000",0,+5,+3,-5
131,,2013-10-25 16:31:31,2013-10-25,DGX,Pfeiffer Gary M,Dir,S - Sale,$58.10,"-2,000","13,927",-13%,"-$116,200",+1,+2,+6,-4
132,DM,2013-09-18 16:43:00,2013-09-16,DGX,Doherty Catherine T.,"SVP, Clinical Franchises",S - Sale+OE,$62.00,"-43,334","75,798",-36%,"-$2,686,708",0,0,-5,-9
133,D,2013-08-15 16:32:42,2013-08-14,DGX,Doherty Catherine T.,"SVP, Clinical Franchises",S - Sale+OE,$59.85,"-33,000","75,794",-30%,"-$1,975,126",-1,+1,+4,-10
134,,2013-08-12 16:46:56,2013-08-12,DGX,Ziegler John B,Dir,S - Sale,$59.45,"-1,953","15,876",-11%,"-$116,109",0,-2,+4,-12
135,D,2013-08-12 16:45:21,2013-08-08,DGX,Bongiorno Thomas F,"VP, Corporate Controller",S - Sale+OE,$59.33,"-10,864","17,152",-39%,"-$644,585",0,-2,+4,-12
136,,2013-07-25 16:40:11,2013-07-23,DGX,Britell Jenne K,Dir,S - Sale,$58.99,"-4,200","12,227",-26%,"-$247,767",0,-1,0,-6
137,DM,2013-06-19 16:35:19,2013-06-17,DGX,Prevoznik Michael E,"SVP, GC",S - Sale+OE,$62.64,"-126,667","49,639",-72%,"-$7,934,171",-2,-2,-4,-11
138,D,2013-05-23 18:47:03,2013-05-22,DGX,Ziegler John B,Dir,S - Sale+OE,$62.00,"-31,362","17,829",-64%,"-$1,944,444",+1,+1,-1,0
139,,2013-05-15 16:39:24,2013-05-14,DGX,Baldwin John C Md,Dir,S - Sale,$59.41,"-1,214","8,634",-12%,"-$72,122",0,+2,+5,+7
140,D,2013-05-03 16:33:25,2013-05-02,DGX,Wilensky Gail R,Dir,S - Sale+OE,$57.20,"-10,000","13,952",-42%,"-$572,008",+1,+3,+9,+5
141,D,2013-04-12 16:39:01,2013-04-11,DGX,Ziegler John B,Dir,S - Sale+OE,$58.35,"-1,470","15,854",-8%,"-$85,775",-2,-6,+1,+5
142,,2013-03-07 16:32:01,2013-03-06,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$56.46,"-1,992","49,557",-4%,"-$112,465",+1,+1,+3,+9
143,,2013-03-06 16:45:24,2013-03-06,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$56.64,-778,"49,557",-2%,"-$44,063",-2,0,+3,+6
144,,2013-02-22 16:33:22,2013-02-20,DGX,Ziegler John B,Dir,S - Sale,$57.42,"-2,000","15,854",-11%,"-$114,840",0,+1,+1,+7
145,D,2013-02-22 16:31:58,2013-02-20,DGX,Britell Jenne K,Dir,S - Sale+OE,$57.30,"-10,000","14,452",-41%,"-$572,957",0,+1,+1,+7
146,,2013-02-19 16:50:49,2013-02-19,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$57.53,"-1,442","45,516",-3%,"-$82,961",-1,-3,-2,+2
147,,2013-02-12 17:00:50,2013-02-12,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$57.48,"-3,481","47,814",-7%,"-$200,074",0,+1,-2,+6
148,D,2013-01-18 16:30:56,2013-01-17,DGX,Pfeiffer Gary M,Dir,S - Sale+OE,$60.00,"-10,000","13,952",-42%,"-$600,000",+1,-6,-6,-3
149,D,2012-10-05 16:24:40,2012-10-03,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$64.00,"-46,667","156,384",-23%,"-$2,986,688",+1,0,-8,-10
150,D,2012-09-07 16:30:35,2012-09-06,DGX,Ziegler John B,Dir,S - Sale+OE,$62.32,"-10,000","17,854",-36%,"-$623,192",-1,0,+4,-9
151,D,2012-08-16 16:18:34,2012-08-15,DGX,Wilensky Gail R,Dir,S - Sale+OE,$59.24,"-20,000","13,952",-59%,"-$1,184,718",0,0,+3,-3
152,D,2012-08-14 16:12:55,2012-08-10,DGX,Buehler William F,Dir,S - Sale+OE,$59.31,"-30,000","24,250",-55%,"-$1,779,164",0,+2,+3,-4
153,D,2012-08-09 16:20:02,2012-08-08,DGX,Doherty Catherine T.,"SVP, Physician Services",S - Sale+OE,$60.11,"-40,000","69,457",-37%,"-$2,404,324",-1,-1,+4,-2
154,D,2012-08-09 16:18:58,2012-08-08,DGX,Baldwin John C Md,Dir,S - Sale+OE,$60.00,"-11,770","9,848",-54%,"-$706,165",-1,-1,+4,-2
155,,2012-08-07 16:20:44,2012-08-07,DGX,Rusckowski Stephen H,"Pres, CEO",P - Purchase,$59.34,"+5,000","68,034",+8%,"+$296,677",+1,0,+3,0
156,,2012-08-06 16:09:34,2012-08-03,DGX,Ziegler John B,Dir,S - Sale,$59.26,"-2,800","17,854",-14%,"-$165,916",+1,+1,+3,-1
157,DM,2012-08-02 16:07:06,2012-07-31,DGX,Prevoznik Michael E,"SVP, GC",S - Sale+OE,$58.66,"-115,259","52,504",-69%,"-$6,760,569",+2,+3,+3,0
158,D,2012-07-13 16:13:05,2012-07-12,DGX,Stanzione Daniel,Dir,S - Sale+OE,$62.00,"-30,000","20,176",-60%,"-$1,860,000",+1,-3,-6,-5
159,D,2012-07-03 13:31:43,2012-06-29,DGX,Bongiorno Thomas F,"VP, Corporate Controller",S - Sale+OE,$59.54,"-15,000","13,977",-52%,"-$893,100",-1,0,-4,-3
160,D,2012-07-03 13:28:14,2012-06-29,DGX,Ziegler John B,Dir,S - Sale+OE,$60.00,"-1,460","20,654",-7%,"-$87,600",-1,0,-4,-3
161,D,2012-07-02 17:22:00,2012-06-28,DGX,Ziegler John B,Dir,S - Sale+OE,$59.00,"-20,000","20,654",-49%,"-$1,180,000",-1,0,-3,-3
162,D,2012-05-31 16:40:32,2012-05-30,DGX,Ziegler John B,Dir,S - Sale+OE,$58.13,-864,"20,654",-4%,"-$50,224",-3,-4,+4,+3
163,,2012-05-09 16:40:55,2012-05-08,DGX,Rusckowski Stephen H,"Pres, CEO",P - Purchase,$56.89,"+20,000","63,034",+46%,"+$1,137,748",+1,0,-4,+2
164,,2012-05-09 16:39:50,2012-05-08,DGX,Bongiorno Thomas F,"VP, Corporate Controller",S - Sale,$56.83,-1,"13,947",0%,-$57,+1,0,-4,+2
165,,2012-05-03 17:53:04,2012-05-01,DGX,Bongiorno Thomas F,"VP, Corporate Controller",S - Sale,$58.43,"-2,305","13,947",-14%,"-$134,686",-1,-1,-5,+1
166,D,2012-05-03 16:34:40,2012-05-02,DGX,Pfeiffer Gary M,Dir,S - Sale+OE,$58.30,"-10,000","11,977",-46%,"-$583,041",-1,-1,-5,+1
167,D,2012-05-03 16:33:42,2012-05-01,DGX,Baldwin John C Md,Dir,S - Sale+OE,$57.50,"-10,334","9,643",-52%,"-$594,205",-1,-1,-5,+1
168,D,2012-04-03 16:20:59,2012-04-02,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$62.00,"-46,666","156,337",-23%,"-$2,893,292",-1,-5,-5,+3
169,,2012-03-02 16:50:12,2012-03-01,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$57.40,"-7,207","40,991",-15%,"-$413,656",0,0,+6,+5
170,D,2012-02-27 16:14:57,2012-02-24,DGX,Miller Joan Elizabeth,"SVP-Oncology, Neurology Srvcs",S - Sale+OE,$57.45,"-15,561","74,420",-17%,"-$893,979",+1,0,+5,+4
171,D,2012-02-22 16:15:24,2012-02-21,DGX,Bongiorno Thomas F,"VP, Corporate Controller",S - Sale+OE,$57.50,"-7,078","19,368",-27%,"-$406,985",0,+2,+5,+7
172,,2012-02-17 16:40:55,2012-02-16,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$57.38,"-1,462","36,027",-4%,"-$83,888",+1,0,+5,+5
173,,2012-02-16 16:18:38,2012-02-14,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$57.40,"-4,544","37,490",-11%,"-$260,822",0,-1,+4,+4
174,D,2012-02-07 16:05:34,2012-02-03,DGX,Miller Joan Elizabeth,"SVP-Oncology, Neurology Srvcs",S - Sale+OE,$58.50,"-13,333","78,912",-14%,"-$779,981",0,-1,-1,+2
175,DM,2012-02-01 16:16:56,2012-01-30,DGX,Mohapatra Surya N,"COB, Pres, CEO",S - Sale+OE,$58.21,"-110,556","272,955",-29%,"-$6,435,542",0,0,0,+1
176,D,2012-01-30 16:44:45,2012-01-27,DGX,Wilensky Gail R,Dir,S - Sale+OE,$58.93,"-30,000","11,977",-71%,"-$1,767,868",0,+1,0,+1
177,D,2012-01-30 16:42:23,2012-01-27,DGX,Stanzione Daniel,Dir,S - Sale+OE,$59.00,"-30,000","18,201",-62%,"-$1,770,006",0,+1,0,+1
178,D,2012-01-30 16:41:25,2012-01-26,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$59.16,"-113,334","141,447",-44%,"-$6,704,271",0,+1,0,+1
179,DM,2012-01-30 16:40:20,2012-01-26,DGX,Mohapatra Surya N,"COB, Pres, CEO",S - Sale+OE,$59.09,"-340,000","362,954",-48%,"-$20,091,434",0,+1,0,+1
180,D,2012-01-30 16:39:24,2012-01-26,DGX,Baldwin John C Md,Dir,S - Sale+OE,$59.00,"-10,000","11,977",-46%,"-$590,005",0,+1,0,+1
181,D,2012-01-30 16:37:58,2012-01-26,DGX,Buehler William F,Dir,S - Sale+OE,$58.83,"-30,000","22,275",-57%,"-$1,764,774",0,+1,0,+1
182,D,2012-01-04 16:07:52,2012-01-03,DGX,Mohapatra Surya N,"COB, Pres, CEO",S - Sale+OE,$58.66,"-20,556","362,641",-5%,"-$1,205,862",0,0,+1,+5
183,D,2011-12-22 16:18:53,2011-12-21,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$57.75,"-4,150","141,442",-3%,"-$239,671",0,-2,+3,-2
184,D,2011-12-02 16:23:40,2011-12-01,DGX,Mohapatra Surya N,"COB, Pres, CEO",S - Sale+OE,$57.95,"-20,556","362,642",-5%,"-$1,191,187",-2,-4,-1,-5
185,D,2011-12-02 16:22:23,2011-12-01,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$58.15,"-4,150","141,443",-3%,"-$241,317",-2,-4,-1,-5
186,D,2011-11-22 16:14:49,2011-11-21,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$54.40,"-4,150","141,443",-3%,"-$225,760",-1,+1,+4,+3
187,D,2011-11-10 16:18:39,2011-11-08,DGX,Bongiorno Thomas F,"VP, Corporate Controller",S - Sale+OE,$57.50,"-13,334","20,448",-39%,"-$766,705",+1,-3,0,+1
188,D,2011-11-03 16:20:35,2011-11-03,DGX,Britell Jenne K,Dir,S - Sale+OE,$55.70,"-7,500","12,477",-38%,"-$417,750",0,0,+5,+3
189,D,2011-11-03 16:19:18,2011-11-01,DGX,Mohapatra Surya N,"COB, Pres, CEO",S - Sale+OE,$54.69,"-20,556","362,645",-5%,"-$1,124,142",0,0,+5,+3
190,D,2011-11-03 16:17:38,2011-11-01,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$54.80,"-4,150","141,443",-3%,"-$227,423",0,0,+5,+3
191,D,2011-11-01 16:26:42,2011-10-28,DGX,Ziegler John B,Dir,S - Sale+OE,$57.28,"-12,997","18,679",-41%,"-$744,501",+2,+4,+7,+7
192,D,2011-11-01 16:25:24,2011-10-28,DGX,Miller Joan Elizabeth,"SVP-Oncology, Neurology Srvcs",S - Sale+OE,$57.50,"-19,259","78,783",-20%,"-$1,107,393",+2,+4,+7,+7
193,D,2011-11-01 16:24:20,2011-10-28,DGX,Mohapatra Surya N,"COB, Pres, CEO",S - Sale+OE,$57.41,"-50,000","362,642",-12%,"-$2,870,500",+2,+4,+7,+7
194,D,2011-10-31 15:39:43,2011-10-27,DGX,Prevoznik Michael E,"SVP, GC",S - Sale+OE,$56.68,"-116,000","45,390",-72%,"-$6,574,892",-3,-3,-2,+3
195,D,2011-10-27 16:09:33,2011-10-25,DGX,Mohapatra Surya N,"COB, Pres, CEO",S - Sale+OE,$56.49,"-48,047","362,643",-12%,"-$2,714,175",+1,-2,-4,+2
196,D,2011-10-25 16:13:27,2011-10-21,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$49.29,"-4,150","141,429",-3%,"-$204,554",-1,-1,-1,+4
197,D,2011-10-05 16:23:48,2011-10-03,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$49.23,"-4,150","141,431",-3%,"-$204,315",+1,+3,+19,+31
198,D,2011-09-23 16:14:45,2011-09-21,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$49.51,"-4,150","141,430",-3%,"-$205,467",+3,+5,+4,+24
199,D,2011-09-06 16:29:31,2011-09-01,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$49.98,"-4,150","141,429",-3%,"-$207,410",+3,-1,-4,+17
200,D,2011-08-31 16:18:32,2011-08-29,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$49.00,"-4,150","141,429",-3%,"-$203,350",-1,+2,+1,+17
201,,2011-08-18 16:37:12,2011-08-17,DGX,Bongiorno Thomas F,"VP, Corporate Controller",S - Sale,$49.29,"-1,500","20,327",-7%,"-$73,939",-1,+3,+4,+22
202,D,2011-08-03 16:09:17,2011-08-01,DGX,Mohapatra Surya N,"COB, Pres, CEO",S - Sale+OE,$54.12,"-13,620","362,450",-4%,"-$737,093",-3,-5,-2,+14
203,D,2011-08-03 16:07:41,2011-08-01,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$54.27,"-4,150","141,428",-3%,"-$225,218",-3,-5,-2,+14
204,D,2011-07-25 11:52:44,2011-07-21,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$57.18,"-4,150","141,415",-3%,"-$237,304",-1,-5,-19,0
205,D,2011-07-05 16:45:01,2011-07-01,DGX,Mohapatra Surya N,"COB, Pres, CEO",S - Sale+OE,$58.96,"-20,555","362,242",-5%,"-$1,211,954",+1,-2,-14,-2
206,D,2011-07-05 16:41:20,2011-07-01,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$58.98,"-4,150","141,411",-3%,"-$244,749",+1,-2,-14,-2
207,D,2011-06-22 11:45:51,2011-06-21,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$60.68,"-4,150","141,411",-3%,"-$251,811",0,-3,-6,-8
208,D,2011-06-20 16:31:34,2011-06-16,DGX,Simmons Wayne R.,"VP, Operations",S - Sale+OE,$60.00,"-16,000","47,752",-25%,"-$960,000",0,-2,-3,-7
209,,2011-06-20 16:28:16,2011-06-16,DGX,Miller Joan Elizabeth,"SVP-Oncology, Neurology Srvcs",S - Sale,$60.20,"-3,815","78,622",-5%,"-$229,663",0,-2,-3,-7
210,,2011-06-16 16:38:49,2011-06-14,DGX,Miller Joan Elizabeth,"SVP-Oncology, Neurology Srvcs",S - Sale,$59.70,"-4,668","82,437",-5%,"-$278,680",+1,+1,-3,-7
211,,2011-06-14 16:29:51,2011-06-13,DGX,Miller Joan Elizabeth,"SVP-Oncology, Neurology Srvcs",S - Sale,$59.20,"-10,615","87,105",-11%,"-$628,408",0,+2,-2,-4
212,D,2011-06-03 16:06:05,2011-06-01,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$58.10,"-4,150","141,412",-3%,"-$241,103",0,+1,+3,+1
213,D,2011-06-02 16:23:30,2011-06-01,DGX,Mohapatra Surya N,"COB, Pres, CEO",S - Sale+OE,$58.06,"-20,555","362,244",-5%,"-$1,193,512",0,0,+2,-3
214,D,2011-05-25 16:18:03,2011-05-23,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$57.46,"-4,150","141,412",-3%,"-$238,456",-1,+1,+5,-5
215,DM,2011-05-19 16:33:44,2011-05-18,DGX,Miller Joan Elizabeth,"SVP-Oncology, Neurology Srvcs",S - Sale+OE,$58.08,"-22,921","97,700",-19%,"-$1,331,301",0,-1,+4,-3
216,D,2011-05-16 16:23:42,2011-05-12,DGX,Miller Joan Elizabeth,"SVP-Pathology, Hosp. Services",S - Sale+OE,$57.41,"-42,365","99,511",-30%,"-$2,432,283",0,+1,+3,0
217,,2011-05-13 16:06:04,2011-05-11,DGX,Simmons Wayne R.,"VP, Operations",S - Sale,$57.00,"-10,000","47,711",-17%,"-$570,000",0,+2,+3,-3
218,D,2011-05-04 16:17:13,2011-05-02,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$56.46,"-4,150","141,413",-3%,"-$234,314",0,+2,+4,0
219,D,2011-05-04 16:09:46,2011-05-02,DGX,Mohapatra Surya N,"COB, Pres, CEO",S - Sale+OE,$56.68,"-20,555","362,247",-5%,"-$1,165,144",0,+2,+4,0
220,D,2011-04-25 16:11:39,2011-04-21,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$58.28,"-4,150","141,402",-3%,"-$241,870",0,+1,+4,-12
221,D,2011-04-05 16:54:23,2011-04-01,DGX,Mohapatra Surya N,"COB, Pres, CEO",S - Sale+OE,$57.70,"-20,555","362,047",-5%,"-$1,185,987",+1,0,-3,-20
222,D,2011-04-05 16:52:07,2011-04-01,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$57.78,"-4,150","141,399",-3%,"-$239,793",+1,0,-3,-20
223,D,2011-03-23 16:19:20,2011-03-21,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$54.20,"-4,150","141,401",-3%,"-$224,910",+1,+6,+8,-7
224,,2011-03-11 16:29:04,2011-03-09,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$57.50,"-2,596","45,390",-5%,"-$149,266",-2,-6,+1,-14
225,D,2011-03-03 16:12:15,2011-03-01,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$56.77,"-4,150","146,010",-3%,"-$235,582",+1,+2,+2,-12
226,D,2011-03-03 16:09:48,2011-03-01,DGX,Mohapatra Surya N,"COB, Pres, CEO",S - Sale+OE,$56.75,"-20,555","373,138",-5%,"-$1,166,535",+1,+2,+2,-12
227,,2011-02-22 17:02:39,2011-02-18,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$57.46,"-8,685","50,220",-15%,"-$499,045",+1,+1,-4,-17
228,D,2011-02-17 18:00:55,2011-02-16,DGX,Miller Joan Elizabeth,"SVP-Pathology, Hosp. Services",S - Sale+OE,$57.40,"-26,666","103,957",-20%,"-$1,530,628",0,-2,-6,-15
229,M,2011-02-16 16:28:33,2011-02-11,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$57.19,"-19,997","41,028",-33%,"-$1,143,598",0,-1,-5,-14
230,,2011-02-14 19:43:31,2011-02-14,DGX,Prevoznik Michael E,"SVP, GC",S - Sale,$57.17,"-1,503","60,944",-2%,"-$85,922",-1,+1,-4,-16
231,D,2011-02-10 17:07:42,2011-02-09,DGX,Mohapatra Surya N,"COB, Pres, CEO",S - Sale+OE,$57.53,"-152,000","302,211",-33%,"-$8,745,122",+1,0,+1,-18
232,D,2011-02-10 17:06:46,2011-02-09,DGX,Baldwin John C Md,Dir,S - Sale+OE,$57.56,"-30,000","10,002",-75%,"-$1,726,881",+1,0,+1,-18
233,D,2011-02-09 16:36:39,2011-02-08,DGX,Ziegler John B,Dir,S - Sale+OE,$58.57,"-21,180","16,704",-56%,"-$1,240,426",-1,-1,-1,-15
234,D,2011-02-09 16:35:00,2011-02-07,DGX,Wilensky Gail R,Dir,S - Sale+OE,$58.57,"-20,000","15,226",-57%,"-$1,171,382",-1,-1,-1,-15
235,D,2011-02-09 16:33:22,2011-02-07,DGX,Stanzione Daniel,Dir,S - Sale+OE,$58.92,"-20,000","16,226",-55%,"-$1,178,322",-1,-1,-1,-15
236,D,2011-02-09 16:32:11,2011-02-07,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$58.92,"-99,287","116,674",-46%,"-$5,849,504",-1,-1,-1,-15
237,D,2011-02-09 16:30:56,2011-02-07,DGX,Bongiorno Thomas F,"VP, Corporate Controller",S - Sale+OE,$58.75,"-28,729","16,943",-63%,"-$1,687,757",-1,-1,-1,-15
238,,2011-02-02 13:55:59,2011-01-31,DGX,Glaxosmithkline Plc,"Dir, 10%",S - Sale,$54.96,"-30,755,151",0,-100%,"-$1,690,226,243",+1,+2,-1,-10
239,D,2010-05-05 16:13:31,2010-05-03,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$57.05,"-3,571","116,626",-3%,"-$203,731",-3,-3,-7,-13
240,D,2010-04-05 16:13:47,2010-04-01,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$58.66,"-3,571","116,611",-3%,"-$209,466",-1,-1,-4,-14
241,D,2010-03-03 16:44:14,2010-03-01,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$57.17,"-3,571","105,419",-3%,"-$204,165",0,0,+4,-20
242,D,2010-02-23 16:45:03,2010-02-19,DGX,Mohapatra Surya N,"COB, Pres, CEO",S - Sale+OE,$57.27,"-150,000","273,828",-35%,"-$8,589,790",0,0,+1,-18
243,D,2010-02-22 17:12:22,2010-02-18,DGX,Bongiorno Thomas F,"VP, Corporate Controller",S - Sale+OE,$57.66,"-5,197","19,075",-21%,"-$299,666",-1,-1,+1,-19
244,D,2010-02-05 16:12:54,2010-02-03,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$56.54,"-75,000","87,831",-46%,"-$4,240,778",-1,+1,+1,-13
245,D,2009-11-10 16:34:29,2009-11-06,DGX,Miller Joan Elizabeth,"SVP-Pathology, Hosp. Services",S - Sale+OE,$57.70,"-21,800","63,440",-26%,"-$1,257,860",-1,+1,0,-5
246,D,2009-11-06 16:26:44,2009-11-04,DGX,Simmons Wayne R.,"VP, Operations",S - Sale+OE,$56.91,"-19,767","28,614",-41%,"-$1,124,964",+1,+1,+2,-5
247,D,2009-11-06 16:22:55,2009-11-04,DGX,Miller Joan Elizabeth,"SVP-Pathology, Hosp. Services",S - Sale+OE,$56.95,"-20,000","63,441",-24%,"-$1,139,020",+1,+1,+2,-5
248,D,2009-10-27 16:34:57,2009-10-23,DGX,Simmons Wayne R.,"VP, Operations",S - Sale+OE,$56.50,-100,"24,318",0%,"-$5,650",0,0,+5,+1
249,D,2009-10-27 16:33:02,2009-10-23,DGX,Bongiorno Thomas F,"VP, Corporate Controller",S - Sale+OE,$56.87,"-4,230","16,039",-21%,"-$240,579",0,0,+5,+1
250,DM,2009-08-24 16:25:10,2009-08-20,DGX,Miller Joan Elizabeth,"SVP-Pathology, Hosp. Services",S - Sale+OE,$54.59,"-35,217","63,332",-36%,"-$1,922,607",0,-1,-4,+3
251,,2009-08-18 16:29:41,2009-08-17,DGX,Miller Joan Elizabeth,"SVP-Pathology, Hosp. Services",S - Sale,$54.80,"-5,514","76,054",-7%,"-$302,167",+1,+3,-2,+7
252,D,2009-08-17 16:33:25,2009-08-13,DGX,Mohapatra Surya N,"COB, Pres, CEO",S - Sale+OE,$53.51,"-11,236","230,313",-5%,"-$601,204",-1,+1,-2,+5
253,D,2009-08-05 16:36:06,2009-08-03,DGX,Buehler William F,Dir,S - Sale+OE,$54.13,"-20,000","18,629",-52%,"-$1,082,694",+1,+1,+1,+8
254,D,2009-07-30 16:37:41,2009-07-29,DGX,Prevoznik Michael E,"SVP, GC",S - Sale+OE,$55.12,"-68,000","48,404",-58%,"-$3,748,228",0,-3,+2,+3
255,DM,2009-07-29 16:41:27,2009-07-27,DGX,Miller Joan Elizabeth,"SVP-Pathology, Hosp. Services",S - Sale+OE,$56.20,"-23,500","81,538",-22%,"-$1,320,700",-2,-3,0,+3
256,D,2009-07-29 16:40:40,2009-07-27,DGX,Bongiorno Thomas F,"VP, Corporate Controller",S - Sale+OE,$56.00,"-3,000","15,907",-16%,"-$168,008",-2,-3,0,+3
257,D,2009-07-27 16:54:49,2009-07-23,DGX,Mohapatra Surya N,"COB, Pres, CEO",S - Sale+OE,$55.56,"-152,000","230,311",-40%,"-$8,444,700",-3,-2,0,+4
258,,2009-07-27 16:53:26,2009-07-23,DGX,Miller Joan Elizabeth,"SVP-Pathology, Hosp. Services",S - Sale,$56.00,"-4,274","81,538",-5%,"-$239,344",-3,-2,0,+4
259,D,2009-07-27 16:50:01,2009-07-23,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$55.61,"-112,218","87,542",-56%,"-$6,240,214",-3,-2,0,+4
260,M,2009-03-19 19:13:16,2009-03-17,DGX,Glaxosmithkline Plc,"Dir, 10%",S - Sale,$44.55,"-5,749,157","30,755,151",-16%,"-$256,143,083",+1,+5,+13,+18
261,,2009-02-26 16:33:25,2009-02-24,DGX,Miller Joan Elizabeth,"SVP-Pathology, Hosp. Services",S - Sale,$51.10,"-10,000","84,290",-11%,"-$511,000",-5,-4,-2,+15
262,D,2009-02-25 16:58:05,2009-02-24,DGX,Wilensky Gail R,Dir,S - Sale+OE,$51.27,"-12,000","11,892",-50%,"-$615,215",-5,-10,-7,+10
263,D,2009-02-23 16:35:53,2009-02-19,DGX,Prevoznik Michael E,"SVP, GC",S - Sale+OE,$50.82,"-18,930","45,524",-29%,"-$961,979",+3,-8,-8,+9
264,DM,2009-02-20 17:12:54,2009-02-18,DGX,Bongiorno Thomas F,"VP, Corporate Controller",S - Sale+OE,$50.74,"-13,103","14,973",-47%,"-$664,872",-2,-6,-12,+6
265,,2009-02-10 17:31:26,2009-02-06,DGX,Miller Joan Elizabeth,"SVP-Pathology, Hosp. Services",S - Sale,$52.25,"-5,000","82,446",-6%,"-$261,250",+1,0,-12,+6
266,D,2009-02-10 17:28:22,2009-02-06,DGX,Ziegler John B,Dir,S - Sale+OE,$52.01,"-20,966","13,370",-61%,"-$1,090,377",+1,0,-12,+6
267,D,2009-02-04 16:39:10,2009-02-02,DGX,Mohapatra Surya N,"COB, Pres, CEO",S - Sale+OE,$49.75,"-10,884","171,157",-6%,"-$541,479",+2,0,-11,+7
268,D,2008-11-14 16:32:41,2008-11-13,DGX,Haggerty Rosanne,Dir,S - Sale+OE,$45.95,"-14,268","6,000",-70%,"-$655,615",-4,-15,-1,+7
269,DM,2008-11-07 16:31:34,2008-11-05,DGX,Mohapatra Surya N,"COB, Pres, CEO",S - Sale+OE,$47.19,"-120,232","171,151",-41%,"-$5,674,167",0,+2,+1,+13
270,D,2007-07-31 17:03:01,2007-07-27,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$55.51,"-12,502","68,076",-16%,"-$693,952",+1,+2,-2,-10
271,D,2007-02-27 18:13:29,2007-02-26,DGX,Grant William R,Dir,S - Sale+OE,$51.91,"-80,135","3,334",-96%,"-$4,159,984",0,-3,-3,+9
272,D,2007-02-27 16:23:10,2007-02-23,DGX,Grant William R,Dir,S - Sale+OE,$52.36,"-75,000","3,334",-96%,"-$3,927,135",0,-3,-3,+9
273,DM,2007-02-08 17:30:14,2007-02-06,DGX,Bongiorno Thomas F,"Vice Pres, Controller",S - Sale+OE,$52.69,"-13,302","7,110",-65%,"-$700,929",0,+1,-5,+9
274,D,2006-11-01 18:01:57,2006-10-30,DGX,Zewe David M,"SVP, Diagnostic Testing Ops",S - Sale+OE,$49.59,"-102,000","36,041",-74%,"-$5,058,394",0,+3,+7,-1
275,,2006-10-30 16:38:19,2006-10-26,DGX,Stanzione Daniel,Dir,P - Purchase,$49.74,"+1,000","9,558",+12%,"+$49,743",0,0,+3,-1
276,D,2006-05-24 16:32:34,2006-05-22,DGX,Mohapatra Surya N,"COB, Pres, CEO",S - Sale+OE,$57.02,"-76,179","117,091",-39%,"-$4,343,810",+1,-1,+3,-6
277,D,2006-05-19 16:34:14,2006-05-17,DGX,Ziegler John B,Dir,S - Sale+OE,$58.70,"-5,390","7,944",-40%,"-$316,393",-1,-1,0,-7
278,DM,2006-05-15 17:52:23,2006-05-11,DGX,Prevoznik Michael E,"SVP, GC",S - Sale+OE,$57.90,"-42,320","24,124",-64%,"-$2,450,350",0,-2,-2,-14
279,DM,2006-05-12 18:42:51,2006-05-10,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$57.88,"-72,890","66,990",-52%,"-$4,219,161",+1,0,-2,-12
280,DM,2006-05-12 18:19:41,2006-05-10,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$57.88,"-72,890","66,990",-52%,"-$4,219,161",+1,0,-2,-12
281,D,2006-02-24 16:16:25,2006-02-22,DGX,Peters Robert E,"VP, Sales, Marketing",S - Sale+OE,$53.15,"-57,647","14,840",-80%,"-$3,063,846",0,+1,-1,+19
282,D,2005-08-12 17:41:43,2005-08-12,DGX,Bongiorno Thomas F,Controller,P - Purchase,$50.64,"+2,200","6,044",+57%,"+$111,408",0,-1,+3,+4
283,D,2005-08-12 17:41:43,2005-08-11,DGX,Bongiorno Thomas F,Controller,S - Sale+OE,$50.20,"-29,215","6,044",-83%,"-$1,466,571",0,-1,+3,+4
284,,2005-05-18 17:43:06,2005-05-16,DGX,Flaherty James F III,Dir,S - Sale,$106.24,"-5,000","1,000",-83%,"-$531,212",0,-1,-2,-11
285,D,2005-05-13 17:07:52,2005-05-11,DGX,Zewe David M,"SVP, Diagnostic Testing Ops",S - Sale+OE,$106.09,"-31,350","21,052",-60%,"-$3,325,922",+1,+3,0,-8
286,D,2005-05-13 17:05:02,2005-05-11,DGX,Hagemann Robert,"SVP, CFO",S - Sale+OE,$105.25,"-32,490","42,622",-43%,"-$3,419,550",+1,+3,0,-8
287,D,2005-05-03 16:44:45,2005-05-02,DGX,Buehler William F,Dir,S - Sale+OE,$106.66,"-18,000","5,147",-78%,"-$1,919,806",+1,+1,0,-12
288,D,2005-02-10 16:17:45,2005-02-08,DGX,Mohapatra Surya N,"Pres, CEO",S - Sale+OE,$98.50,"-50,799","58,535",-46%,"-$5,003,828",0,0,0,+1
289,ADM,2005-02-03 18:27:27,2005-01-31,DGX,Prevoznik Michael E,"SVP, GC",S - Sale+OE,$94.99,"-24,218","13,419",-64%,"-$2,300,431",+2,+1,+3,+3
290,DM,2005-02-02 18:09:26,2005-01-31,DGX,Prevoznik Michael E,"SVP, GC",S - Sale+OE,$94.99,"-24,218","13,419",-64%,"-$2,300,431",0,+1,+3,+7
291,D,2005-02-02 17:11:08,2005-01-31,DGX,Wilensky Gail R,Dir,S - Sale+OE,$95.12,"-12,000","2,612",-82%,"-$1,141,446",0,+1,+3,+7
292,D,2004-12-15 15:01:28,2004-12-14,DGX,Glaxosmithkline Plc,10%,S - Sale+OE,$94.19,"-2,700,000","18,252,154",-13%,"-$254,313,000",-1,-1,-3,+12
293,D,2004-12-10 17:35:08,2004-12-10,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$94.35,"-26,000","250,566",-9%,"-$2,453,130",0,-2,-5,+9
294,D,2004-12-02 17:29:53,2004-12-01,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$93.46,"-26,000","251,566",-9%,"-$2,430,040",0,+2,+1,+13
295,D,2004-11-26 14:23:47,2004-11-24,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$91.81,"-26,000","252,566",-9%,"-$2,387,135",0,+3,+3,+16
296,D,2004-11-18 16:48:21,2004-11-17,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$91.86,"-26,000","308,566",-8%,"-$2,388,433",-1,0,+2,+19
297,D,2004-11-12 16:27:22,2004-11-10,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$90.90,"-26,000","309,566",-8%,"-$2,363,385",+1,0,+5,+15
298,D,2004-11-04 17:42:22,2004-11-03,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$88.22,"-26,000","310,566",-8%,"-$2,293,720",+1,+1,+5,+19
299,D,2004-10-28 16:39:28,2004-10-27,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$86.33,"-26,000","311,566",-8%,"-$2,244,515",+1,+2,+6,+20
300,D,2004-10-21 16:59:30,2004-10-20,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$84.23,"-26,000","312,566",-8%,"-$2,189,968",0,+3,+8,+22
301,D,2004-10-14 18:20:46,2004-10-13,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$85.43,"-26,000","313,566",-8%,"-$2,221,075",+1,+1,+8,+22
302,D,2004-10-07 17:37:02,2004-10-06,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$87.97,"-26,000","314,566",-8%,"-$2,287,115",-1,-2,+4,+22
303,D,2004-10-01 16:07:00,2004-09-29,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$87.32,"-26,000","315,566",-8%,"-$2,270,420",0,-1,0,+20
304,D,2004-09-23 16:19:30,2004-09-22,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$85.13,"-26,000","316,566",-8%,"-$2,213,333",+1,+3,0,+18
305,D,2004-09-16 16:50:41,2004-09-15,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$84.14,"-26,000","317,566",-8%,"-$2,187,705",-1,+1,0,+17
306,D,2004-09-09 16:16:31,2004-09-08,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$85.49,"-26,000","318,566",-8%,"-$2,222,740",0,-1,+3,+18
307,D,2004-09-01 17:41:45,2004-09-01,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$86.43,"-26,000","319,566",-8%,"-$2,247,188",0,-2,+2,+15
308,D,2004-08-27 16:01:03,2004-08-25,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$83.53,"-26,000","320,566",-8%,"-$2,171,650",-1,+3,+2,+18
309,D,2004-08-19 17:21:03,2004-08-18,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$84.18,"-26,000","321,543",-7%,"-$2,188,623",0,-2,0,+19
310,D,2004-08-17 16:05:41,2004-08-13,DGX,Zewe David M,"SVP, Diagnostic Testing Ops",S - Sale+OE,$82.10,"-8,650","20,979",-29%,"-$710,174",0,-1,0,+18
311,D,2004-08-11 16:35:02,2004-08-11,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$81.65,"-26,000","322,543",-7%,"-$2,122,855",-1,+2,+2,+20
312,D,2004-08-05 17:09:51,2004-08-04,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$80.82,"-26,000","323,543",-7%,"-$2,101,400",-3,+2,+7,+20
313,D,2004-07-29 18:43:38,2004-07-28,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$80.94,"-26,000","324,543",-7%,"-$2,104,463",0,0,+1,+9
314,D,2004-07-22 18:18:05,2004-07-21,DGX,Freeman Kenneth W/nj,Chairman,S - Sale+OE,$83.90,"-26,000","325,543",-7%,"-$2,181,485",-1,-3,0,+10
315,D,2004-07-16 16:27:07,2004-07-14,DGX,Freeman Kenneth W/nj,Chairman,S - Sale+OE,$84.48,"-26,000","326,543",-7%,"-$2,196,588",0,0,-2,+11
316,D,2004-07-08 17:35:05,2004-07-07,DGX,Freeman Kenneth W/nj,Chairman,S - Sale+OE,$84.54,"-26,000","327,543",-7%,"-$2,198,125",0,0,-3,+11
317,D,2004-07-01 17:08:46,2004-06-30,DGX,Freeman Kenneth W/nj,Chairman,S - Sale+OE,$83.40,"-26,000","328,543",-7%,"-$2,168,453",-1,-1,-4,+13
318,D,2004-06-29 17:02:32,2004-06-25,DGX,Glaxosmithkline Plc,10%,S - Sale+OE,$86.13,"-1,176,518","20,952,154",-5%,"-$101,333,495",+1,0,-2,+14
319,D,2004-06-24 17:40:10,2004-06-23,DGX,Freeman Kenneth W/nj,Chairman,S - Sale+OE,$86.19,"-26,000","329,543",-7%,"-$2,240,970",0,-2,-4,+9
320,D,2004-06-17 16:58:12,2004-06-16,DGX,Freeman Kenneth W/nj,Chairman,S - Sale+OE,$87.99,"-26,000","330,543",-7%,"-$2,287,701",0,0,-3,+10
321,D,2004-06-10 16:20:10,2004-06-09,DGX,Freeman Kenneth W/nj,Chairman,S - Sale+OE,$87.69,"-26,000","331,543",-7%,"-$2,280,063",-1,-1,-3,+10
322,D,2004-06-02 17:56:12,2004-06-02,DGX,Freeman Kenneth W/nj,Chairman,S - Sale+OE,$87.59,"-26,000","332,543",-7%,"-$2,277,415",0,0,-3,+7
323,D,2004-05-28 14:29:35,2004-05-26,DGX,Freeman Kenneth W/nj,Chairman,S - Sale+OE,$85.00,"-26,000","333,543",-7%,"-$2,209,983",+1,+3,-2,+8
324,D,2004-05-20 17:03:19,2004-05-19,DGX,Freeman Kenneth W/nj,Chairman,S - Sale+OE,$82.22,"-26,000","334,543",-7%,"-$2,137,610",+1,+3,+5,+12
325,DM,2004-05-18 17:08:29,2004-05-14,DGX,Mohapatra Surya N,"Pres, CEO, 10%",S - Sale+OE,$82.56,"-52,300","58,525",-47%,"-$4,317,952",-1,+1,+6,+14
326,M,2004-05-13 16:59:43,2004-05-12,DGX,Flaherty James F III,Dir,P - Purchase,$82.06,"+4,000","6,000",+200%,"+$328,227",0,-1,+5,+10
327,D,2004-05-12 17:52:01,2004-05-12,DGX,Freeman Kenneth W/nj,Dir,S - Sale+OE,$82.34,"-26,000","335,542",-7%,"-$2,140,795",0,0,+6,+11
328,D,2004-05-07 17:44:12,2004-05-06,DGX,Hagemann Robert,"Corp.VP, Chief Fin. Officer",S - Sale+OE,$86.26,"-23,168","42,078",-36%,"-$1,998,518",-2,-2,+5,+7
329,D,2004-05-06 19:00:31,2004-05-06,DGX,Ziegler John B,Dir,S - Sale+OE,$86.00,"-5,000",0,-100%,"-$430,000",-2,-4,+3,+4
330,D,2004-05-06 18:01:15,2004-05-05,DGX,Freeman Kenneth W/nj,Dir,S - Sale+OE,$85.13,"-26,000","323,838",-7%,"-$2,213,295",-2,-4,+3,+4
331,,2004-05-04 17:44:13,2004-05-03,DGX,Bongiorno Thomas F,"VP, Corporate Controller",S - Sale,$85.00,"-2,443",208,-92%,"-$207,655",+1,-3,+3,+4
332,D,2004-05-04 17:19:59,2004-05-01,DGX,Freeman Kenneth W/nj,Chairman of the Board,S - Sale+OE,$84.18,"-26,324","324,838",-7%,"-$2,216,073",+1,-3,+3,+4
333,D,2004-04-28 19:09:51,2004-04-27,DGX,Stanzione Daniel,Dir,S - Sale+OE,$85.15,"-24,000","2,612",-90%,"-$2,043,708",-1,0,-1,+2
334,M,2004-04-28 17:33:49,2004-04-26,DGX,Brody Kenneth D,Dir,S - Sale,$85.33,"-9,612",0,-100%,"-$820,233",-1,0,-1,+2
335,D,2004-03-17 18:04:44,2004-03-16,DGX,Freeman Kenneth W/nj,"COB, CEO",S - Sale+OE,$82.10,"-20,000","327,764",-6%,"-$1,641,994",+1,0,0,+3
336,D,2004-03-10 17:19:33,2004-03-09,DGX,Freeman Kenneth W/nj,"COB, CEO",S - Sale+OE,$81.31,"-30,000","332,764",-8%,"-$2,439,330",-2,-1,+1,+3
337,D,2004-03-04 16:44:57,2004-03-02,DGX,Freeman Kenneth W/nj,"COB, CEO",S - Sale+OE,$81.08,"-30,000","337,764",-8%,"-$2,432,454",0,0,0,+6
338,D,2004-03-02 16:20:36,2004-02-27,DGX,Zewe David M,"SVP, Diagnostic Testing Ops",S - Sale+OE,$82.91,"-16,823","20,938",-45%,"-$1,394,800",+2,+1,+4,+4
339,D,2004-02-25 18:27:45,2004-02-24,DGX,Marrone Gerald C,"SVP, Administration",S - Sale+OE,$80.29,"-20,000","54,556",-27%,"-$1,605,802",0,-2,-1,+2
340,D,2004-02-25 18:19:38,2004-02-24,DGX,Freeman Kenneth W/nj,"COB, CEO",S - Sale+OE,$80.07,"-30,000","343,727",-8%,"-$2,402,211",0,-2,-1,+2
341,D,2004-02-23 16:41:25,2004-02-20,DGX,Cirillo Mary A,Dir,S - Sale+OE,$79.90,"-7,480","2,627",-74%,"-$597,674",0,+4,+2,+6
342,,2004-02-19 18:04:06,2004-02-18,DGX,Wilensky Gail R,Dir,S - Sale,$82.90,-150,"2,612",-5%,"-$12,435",+1,+3,+4,+6
343,D,2004-02-18 18:14:21,2004-02-17,DGX,Freeman Kenneth W/nj,"COB, CEO",S - Sale+OE,$82.31,"-30,000","348,727",-8%,"-$2,469,372",-3,-2,0,+3
344,D,2004-02-11 16:44:37,2004-02-10,DGX,Freeman Kenneth W/nj,"COB, CEO",S - Sale+OE,$84.68,"-30,000","353,706",-8%,"-$2,540,253",-2,-4,-5,-2
345,D,2004-02-11 16:33:55,2004-02-10,DGX,Wilensky Gail R,Dir,S - Sale+OE,$84.40,"-15,000","2,762",-84%,"-$1,266,048",-2,-4,-5,-2
346,D,2004-02-11 16:27:07,2004-02-09,DGX,Buehler William F,Dir,S - Sale+OE,$84.32,"-15,000","5,147",-74%,"-$1,264,730",-2,-4,-5,-2
347,M,2004-02-11 16:16:35,2004-02-09,DGX,Brody Kenneth D,Dir,S - Sale,$84.96,"-3,000","9,612",-24%,"-$254,890",-2,-4,-5,-2
348,,2004-02-09 16:28:56,2004-02-06,DGX,Brody Kenneth D,Dir,S - Sale,$84.61,"-4,000","12,612",-24%,"-$338,420",+1,-2,-3,-4
349,M,2004-02-05 17:07:09,2004-02-03,DGX,Brody Kenneth D,Dir,S - Sale,$84.98,"-9,000","16,612",-35%,"-$764,775",+1,+1,-3,-3
350,D,2004-02-04 18:10:59,2004-02-03,DGX,Freeman Kenneth W/nj,"COB, CEO",S - Sale+OE,$84.46,"-30,000","358,706",-8%,"-$2,533,920",-1,0,-4,-4
351,DM,2004-02-02 16:29:42,2004-01-29,DGX,Brody Kenneth D,Dir,S - Sale+OE,$83.40,"-13,000","25,612",-34%,"-$1,084,164",0,+1,-5,-1
352,D,2004-02-02 16:22:11,2004-01-29,DGX,Freeman Kenneth W/nj,"COB, CEO",S - Sale+OE,$82.18,"-30,000","363,706",-8%,"-$2,465,400",0,+1,-5,-1
353,D,2004-01-30 18:21:46,2004-01-29,DGX,Prevoznik Michael E,"Corp VP, Legal, Compliance",S - Sale+OE,$82.28,"-23,800","22,919",-51%,"-$1,958,264",-1,-1,-4,-3
354,,2004-01-30 17:54:05,2004-01-29,DGX,Bongiorno Thomas F,"VP, Corporate Controller",S - Sale,$81.76,"-4,270","3,270",-57%,"-$349,094",-1,-1,-4,-3
355,,2003-12-17 16:28:04,2003-12-16,DGX,Freeman Kenneth W/nj,"COB, CEO",S - Sale,$70.66,"-30,000","370,637",-7%,"-$2,119,752",0,0,+10,+25
356,,2003-12-10 16:57:01,2003-12-09,DGX,Freeman Kenneth W/nj,"COB, CEO",S - Sale,$71.47,"-30,000","375,637",-7%,"-$2,144,100",+3,-1,+4,+24
357,,2003-12-02 16:40:08,2003-12-02,DGX,Freeman Kenneth W/nj,"COB, CEO",S - Sale,$73.70,"-30,000","380,637",-7%,"-$2,210,940",-1,-3,-1,+19
358,,2003-11-26 16:05:44,2003-11-25,DGX,Freeman Kenneth W/nj,"COB, CEO",S - Sale,$71.68,"-30,000","386,624",-7%,"-$2,150,400",0,+1,-3,+18
359,,2003-11-21 17:45:54,2003-11-20,DGX,Freeman Kenneth W/nj,"COB, CEO",S - Sale,$70.52,"-30,000","394,112",-7%,"-$2,115,696",0,+2,-3,+17
360,,2003-11-17 17:27:03,2003-11-14,DGX,Cirillo Mary A,Dir,S - Sale,$70.00,"-7,967","2,612",-75%,"-$557,690",-1,0,-2,+16
361,D,2003-08-20 17:41:05,2003-08-20,DGX,Marrone Gerald C,"SVP, Administration",S - Sale+OE,$58.65,"-19,390","57,842",-25%,"-$1,137,224",+1,-1,+7,+36
362,,2003-08-07 17:06:49,2003-08-06,DGX,Flaherty James F III,Dir,P - Purchase,$57.56,"+2,000","2,000",New,"+$115,120",+1,+2,+5,+47
363,M,2003-07-30 17:06:17,2003-07-29,DGX,Zewe David M,SVP -Diagnostic Testg Ops,S - Sale,$60.71,"-15,235","23,153",-40%,"-$924,914",-2,-6,-4,+35
364,,2003-07-29 14:44:57,2003-07-25,DGX,Cirillo Mary A,Dir,S - Sale,$59.23,"-9,000","2,612",-78%,"-$533,070",0,-4,-4,+37
